Orakl Oncology uses Meta's DINOv2 to accelerate cancer organoid analysis and drug response prediction
Orakl Oncology, a spinoff from the Gustave Roussy Institute, has deployed Meta's open-source DINOv2 vision model to analyze cancer organoid images and predict patient drug responses in clinical trials. In collaboration with CentraleSupelec and the Jaulin Lab under the RHU ORGANOMIC initiative, the team found DINOv2 outperformed prior specialized models by 26.8% accuracy. The model enabled quantitative extraction of imaging data from organoid videos, replacing labor-intensive frame-by-frame analysis and significantly accelerating their biomedical platform development.
Related guides (2)
Related events (8)
UPenn PRONTO Team Uses Meta's SAM 2 and DINO for Autonomous Military Medical Triage in DARPA Challenge
The University of Pennsylvania's PRONTO team is applying Meta's Segment Anything Model 2 (SAM 2) and DINO/Grounding DINO models to autonomous robotic triage in DARPA's three-year mass casualty incident challenge. The multi-robot system uses drones and ground robots to locate victims, then runs parallel injury classification pipelines combining SAM, DINO, and pose estimation to assess heart rate, respiration, wounds, and amputations without requiring labeled training data. Results are surfaced to first responders via a mobile interface for real-time prioritization. Phase 2 concluded in October 2025, with Phase 3 expected to push toward deployment-ready performance.
Forest Research Deploys DINOv2 for National-Scale Tree Canopy Monitoring in England
Forest Research, the UK Forestry Commission's research agency, is using Meta's DINOv2 computer vision model—trained on 18 million satellite images in collaboration with the World Resources Institute—to build enhanced tree canopy height maps at 1-meter resolution for England. The approach aims to replace expensive LiDAR and survey data with open-source AI-derived canopy height models applied to national aerial photography, enabling rolling three-year monitoring cycles. The deployment supports the UK government's Environmental Improvement Plan targets and the Natural Capital and Ecosystem Assessment program. Meta also announced DINOv3 as a successor to further improve visual intelligence for such applications.
Decoding genetics with OpenAI o1
Geneticist Catherine Brownstein demonstrates OpenAI o1's application to rare disease diagnosis, showing how the model can accelerate the interpretation of complex genetic data. The post highlights o1's reasoning capabilities in a specialized scientific domain. This represents a capability demonstration for o1 in high-stakes medical genetics use cases.
Color Health's Cancer Copilot Uses GPT-4o for Oncology Workup Planning
Color Health has partnered with OpenAI to deploy GPT-4o in a clinical application called Cancer Copilot, designed to identify missing diagnostics and generate tailored cancer workup plans. The system aims to accelerate patient access to cancer screening and treatment by supporting evidence-based clinical decision-making. This represents a concrete enterprise deployment of GPT-4o in a high-stakes medical context.
Meta and World Resources Institute Release Canopy Height Maps v2 Using DINOv3 Self-Supervised Vision Model
Meta AI and the World Resources Institute have released Canopy Height Maps v2 (CHMv2), an open-source global forest mapping system powered by DINOv3, Meta's self-supervised vision model pre-trained on SAT-493M, a large satellite imagery dataset. The new model improves R² accuracy from 0.53 to 0.86 over the previous DINOv2-based version, with better performance on tall trees and greater geographic consistency. CHMv2 is already being adopted by the UK Forestry Commission, the European Commission's Joint Research Centre, and multiple US city planning initiatives. The model, maps, and dataset are publicly available.
Rogo scales AI-driven financial research with OpenAI o1
Rogo, an AI-powered financial research platform, is using OpenAI's o1 reasoning model to scale its financial analysis capabilities. The deployment focuses on applying o1's advanced reasoning to complex financial research tasks. This represents an enterprise use case of frontier reasoning models in the financial services domain.
Atlas H&E-TME: AI system matches expert pathologist accuracy for scalable tumor microenvironment profiling
Researchers present Atlas H&E-TME, an AI system built on the Atlas family of pathology foundation models that generates over 4,500 quantitative readouts per whole-slide H&E image at cell-level resolution across multiple cancer types. The system is validated using a novel dual framework: an IHC-informed multi-pathologist consensus protocol for depth, and benchmarking against 200,000+ annotations across 1,500+ cases from 25+ sources spanning eight cancer types. Atlas H&E-TME matches or exceeds pathologist H&E-only performance, demonstrating that standard histopathology slides can serve as a scalable quantitative window into the tumor microenvironment. The work advances computational pathology by enabling tissue-based biomarker discovery without requiring specialized staining modalities.
Meta Introduces TRIBE v2: Predictive Foundation Model for Human Brain Activity
Meta AI has released TRIBE v2, a foundation model that predicts high-resolution fMRI brain activity in response to visual, auditory, and language stimuli. Trained on data from over 700 healthy volunteers, it achieves a 70x resolution increase over comparable models and supports zero-shot generalization to new subjects, languages, and tasks. The release includes model weights, codebase, a research paper, and an interactive demo under a CC BY-NC license. Meta positions the work as a bridge between neuroscience and AI development, enabling hypothesis testing without requiring human subjects in every experiment.